IP Library Granted Patent US 12,377,279
Granted Patent B2
US 12,377,279 · App. 18/390,583 · Granted Aug 5, 2025

Wearable cardioverter defibrillator (WCD) system detecting QRS complexes in ECG signal by matched difference filter

Inventor: Joseph L. Sullivan (Kirkland, WA)
Assignee: West Affum Holdings DAC
A61N1/3987A61B5/366A61N1/3904A61N1/3925
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,377,279
App. No.
18/390,583
Granted
Aug 5, 2025
Kind
B2
Abstract

In embodiments, a wearable cardioverter defibrillator (WCD) system includes electrodes that render an ECG signal of the patient, and a processor that receives ECG data are derived from the rendered ECG signal. The processor may filter the received ECG data with a matched difference filter to detect QRS complexes, and compute a heart rate from the detected QRS complexes. The matched difference filter itself can have coefficient values associated with a baseline QRS complex, which improves detection.

Claims (56)

1. A wearable monitoring device, comprising:

a support structure configured to be worn by a patient;

electrodes configured to obtain an electrocardiogram (ECG) signal of the patient while the patient is wearing the support structure, wherein the electrodes are dry electrodes; and

a processor configured to:

process the ECG signal to detect a QRS complex in the ECG signal using an adaptive matched filter, wherein the adaptive matched filter is configured to detect the QRS complex in the ECG signal having noise caused by friction between the patient and the dry electrodes;

assess similarity between two or more QRS complexes in the ECG signal, and to provide an organization value based on the assessed similarity; and

compute a heart rate of the patient based at least in part on the detected QRS complex and the organization value.

2. The wearable monitoring device of claim 1 , further comprising:

a heart rate monitor to obtain the heart rate of the patient;

wherein the processor is configured to assess agreement between the computed heart rate and the heart rate obtained with the heart rate monitor, and to provide an agreement value based on the assessed agreement.

3. The wearable monitoring device of claim 2 , wherein the processor is configured to update a kernel of the adaptive matched filter when the agreement value is high or when the organization value is high.

4. The wearable monitoring device of claim 2 , wherein the processor is configured to update a kernel of the adaptive matched filter when both the agreement value and the organization value are high.

5. The wearable monitoring device of claim 1 , wherein the ECG signal is processed by the processor without taking a time derivative of the ECG signal.

6. The wearable monitoring device of claim 1 , wherein the processor is configured to take a time derivative of the ECG signal to process the ECG signal.

7. The wearable monitoring device of claim 1 , wherein the ECG signal passes through a series connected capacitor prior to being processed by the processor.

8. The wearable monitoring device of claim 1 , wherein the processor is configured to continuously process the ECG signal using the adaptive matched filter.

9. The wearable monitoring device of claim 1 , wherein the processor is configured to process segments of the ECG signal using the adaptive matched filter.

10. The wearable monitoring device of claim 1 , further comprising:

an energy storage module configured to store an electrical charge; and

a discharge circuit coupled to the energy storage module;

wherein the processor is further configured to:

determine based at least in part on the computed heart rate whether a shock criterion is met; and

responsive to the shock criterion being met, control the discharge circuit to discharge at least a portion of the stored electrical charge through the patient while the support structure is worn by the patient to deliver a shock to the patient.

11. A wearable monitoring device, comprising:

a support structure configured to be worn by a patient;

electrodes configured to obtain an electrocardiogram (ECG) signal of the patient while the patient is wearing the support structure, wherein the electrodes are dry electrodes; and

a processor configured to:

detect a QRS complex in the ECG signal by processing the ECG signal using a first filter and processing the ECG signal using a second filter, and detecting the QRS complex when both the first filter and the second filter output the QRS complex, wherein at least one of the first filter or the second filter is configured to detect the QRS complex in the ECG signal having noise caused by friction between the patient and the dry electrodes, and wherein the first filter is a matched convolution filter and the second filter is a matched difference filter; and

compute a heart rate of the patient based at least in part on the detected QRS complex.

12. The wearable monitoring device of claim 11 , wherein one of the first filter or the second filter is an adaptive matched filter.

13. The wearable monitoring device of claim 11 , wherein the processor is configured to process the ECG signal in segments.

14. The wearable monitoring device of claim 13 , wherein a successive segment at least partially overlaps a previous segment.

15. The wearable monitoring device of claim 11 , wherein the processor is configured to continuously process the ECG signal.

16. The wearable monitoring device of claim 11 , wherein the processor comprises a digital signal processor (DSP), and the first filter and the second filter comprise digital filters.

17. The wearable monitoring device of claim 11 , further comprising:

an energy storage module configured to store an electrical charge;

a discharge circuit coupled to the energy storage module;

wherein the processor is further configured to:

determine based at least in part on the computed heart rate whether a shock criterion is met; and

responsive to the shock criterion being met, control the discharge circuit to discharge at least a portion of the stored electrical charge through the patient while the support structure is worn by the patient to deliver a shock to the patient.

18. A wearable monitoring device, comprising:

a support structure configured to be worn by a patient;

electrodes configured to obtain an electrocardiogram (ECG) signal of the patient while the patient is wearing the support structure; and

a processor configured to:

process the ECG signal to detect a QRS complex in the ECG signal using an adaptive matched filter;

assess similarity between two or more QRS complexes in the ECG signal, and to provide an organization value based on the assessed similarity; and

compute a heart rate of the patient based at least in part on the detected QRS complex and the organization value.

19. The wearable monitoring device of claim 18 , further comprising:

a heart rate monitor to obtain the heart rate of the patient:

wherein the processor is configured to assess agreement between the computed heart rate and the heart rate obtained with the heart rate monitor, and to provide an agreement value based on the assessed agreement, and to update a kernel of the adaptive matched filter when the agreement value is high.

20. The wearable monitoring device of claim 18 , further comprising:

an energy storage module configured to store an electrical charge; and

a discharge circuit coupled to the energy storage module;

wherein the processor is further configured to:

determine based at least in part on the computed heart rate whether a shock criterion is met; and

responsive to the shock criterion being met, control the discharge circuit to discharge at least a portion of the stored electrical charge through the patient while the support structure is worn by the patient to deliver a shock to the patient.

Assignments (12)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2025
From: KESTRA MEDICAL TECHNOLOGIES, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070512/0393 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2025
From: PHYSIO-CONTROL, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070446/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2025
From: PHYSIO-CONTROL DEVELOPMENT CO., LLC
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070446/0469 →
CHANGE OF NAME Recorded Mar 7, 2025
From: WEST AFFUM DEVELOPMENT CO., LLC
To: WEST AFFUM DEVELOPMENT CO., INC.
Reel/Frame 070446/0561 →
CHANGE OF NAME Recorded Mar 7, 2025
From: WEST AFFUM DEVELOPMENT CO., INC.
To: KESTRA MEDICAL TECHNOLOGIES, INC.
Reel/Frame 070446/0715 →
CHANGE OF NAME Recorded Mar 7, 2025
From: PHYSIO-CONTROL DEVELOPMENT CO., LLC
To: WEST AFFUM DEVELOPMENT CO., LLC
Reel/Frame 070446/0769 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2025
From: SULLIVAN, JOSEPH L.
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 070439/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2025
From: SULLIVAN, JOSEPH L.
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 070446/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2025
From: PHYSIO-CONTROL DEVELOPMENT CO., LLC
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070383/0912 →
SECURITY INTEREST Recorded Mar 3, 2025
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070388/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2025
From: SULLIVAN, JOSEPH L.
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 070383/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2025
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
Reel/Frame 070383/0794 →
Continuity (4)
Continuation 17392611 · Aug 3, 2021
Continuation 15724317 · Oct 4, 2017
Provisional Application 62404140 · Oct 4, 2016
Related Publication 20240131349A1 · Apr 25, 2024
References Cited (121)
US 3724455A · Unger · 1973 [cited by applicant]
US 4240442A · Andresen et al. · 1980 [cited by applicant]
US 4583524A · Hutchins · 1986 [cited by applicant]
US 4619265A · Morgan et al. · 1986 [cited by applicant]
US 4928690A · Heilman et al. · 1990 [cited by applicant]
US 4955381A · Way et al. · 1990 [cited by applicant]
US 5078134A · Heilman et al. · 1992 [cited by applicant]
US 5228449A · Christ et al. · 1993 [cited by applicant]
US 5271411A · Ripley et al. · 1993 [cited by applicant]
US 5348008A · Bornn et al. · 1994 [cited by applicant]
US 5353793A · Bornn · 1994 [cited by applicant]
US RE34800E · Hutchins · 1994 [cited by applicant]
US 5394892A · Kenny et al. · 1995 [cited by applicant]
US 5405362A · Kramer et al. · 1995 [cited by applicant]
US 5474574A · Payne et al. · 1995 [cited by applicant]
US 5662690A · Cole et al. · 1997 [cited by applicant]
US 5782878A · Morgan et al. · 1998 [cited by applicant]
US 5792204A · Snell · 1998 [cited by applicant]
US 5902249A · Lyster · 1999 [cited by applicant]
US 5913685A · Hutchins · 1999 [cited by applicant]
US 5944669A · Kaib · 1999 [cited by applicant]
US 6047203A · Sackner et al. · 2000 [cited by applicant]
US 6065154A · Hulings et al. · 2000 [cited by applicant]
US 6108197A · Janik · 2000 [cited by applicant]
US 6148233A · Owen et al. · 2000 [cited by applicant]
US 6201992B1 · Freeman · 2001 [cited by applicant]
US 6263238B1 · Brewer et al. · 2001 [cited by applicant]
US 6287328B1 · Snyder et al. · 2001 [cited by applicant]
US 6304780B1 · Owen et al. · 2001 [cited by applicant]
US 6319011B1 · Motti et al. · 2001 [cited by applicant]
US 6334070B1 · Nova et al. · 2001 [cited by applicant]
US 6356785B1 · Snyder et al. · 2002 [cited by applicant]
US 6427083B1 · Owen et al. · 2002 [cited by applicant]
US 6529875B1 · Nakajima et al. · 2003 [cited by applicant]
US 6546285B1 · Owen et al. · 2003 [cited by applicant]
US 6671545B2 · Fincke · 2003 [cited by applicant]
US 6681003B2 · Linder et al. · 2004 [cited by applicant]
US 6762917B1 · Verbiest et al. · 2004 [cited by applicant]
US 7065401B2 · Worden · 2006 [cited by applicant]
US 7559902B2 · Ting et al. · 2009 [cited by applicant]
US 7865238B2 · Brink · 2011 [cited by applicant]
US 7870761B2 · Valentine et al. · 2011 [cited by applicant]
US 7974689B2 · Volpe et al. · 2011 [cited by applicant]
US 8024037B2 · Kumar · 2011 [cited by applicant]
US 8135462B2 · Owen et al. · 2012 [cited by applicant]
US 8140154B2 · Donnelly et al. · 2012 [cited by applicant]
US 8369944B2 · Macho et al. · 2013 [cited by applicant]
US 8548557B2 · Garstka et al. · 2013 [cited by applicant]
US 8615295B2 · Savage et al. · 2013 [cited by applicant]
US 8644925B2 · Volpe et al. · 2014 [cited by applicant]
US 8897860B2 · Volpe et al. · 2014 [cited by applicant]
US 8904214B2 · Volpe et al. · 2014 [cited by applicant]
US 8965500B2 · Macho et al. · 2015 [cited by applicant]
US 9008801B2 · Kaib et al. · 2015 [cited by applicant]
US 9089685B2 · Sullivan et al. · 2015 [cited by applicant]
US 9131901B2 · Volpe et al. · 2015 [cited by applicant]
US 9132267B2 · Kaib · 2015 [cited by applicant]
US 9408548B2 · Volpe et al. · 2016 [cited by applicant]
US 9454219B2 · Volpe et al. · 2016 [cited by applicant]
US 9592403B2 · Sullivan · 2017 [cited by applicant]
US 9757581B2 · Sullivan et al. · 2017 [cited by applicant]
US 10322291B2 · Medema et al. · 2019 [cited by applicant]
US 20030158593A1 · Heilman et al. · 2003 [cited by applicant]
US 20040230105A1 · Geva et al. · 2004 [cited by applicant]
US 20050107833A1 · Freeman et al. · 2005 [cited by applicant]
US 20050107834A1 · Freeman et al. · 2005 [cited by applicant]
US 20080027338A1 · Lu et al. · 2008 [cited by applicant]
US 20080312709A1 · Volpe et al. · 2008 [cited by applicant]
US 20090005827A1 · Weintraub et al. · 2009 [cited by applicant]
US 20100007413A1 · Herleikson et al. · 2010 [cited by applicant]
US 20100298899A1 · Donnelly et al. · 2010 [cited by applicant]
US 20110022105A9 · Owen et al. · 2011 [cited by applicant]
US 20110288604A1 · Kaib et al. · 2011 [cited by applicant]
US 20110288605A1 · Kaib et al. · 2011 [cited by applicant]
US 20120150008A1 · Lanar et al. · 2012 [cited by applicant]
US 20120112903A1 · Kaib et al. · 2012 [cited by applicant]
US 20120144551A1 · Guldalian · 2012 [cited by applicant]
US 20120158075A1 · Kaib et al. · 2012 [cited by applicant]
US 20120265265A1 · Razavi et al. · 2012 [cited by applicant]
US 20120283794A1 · Kaib et al. · 2012 [cited by applicant]
US 20120293323A1 · Kaib et al. · 2012 [cited by applicant]
US 20120302860A1 · Volpe et al. · 2012 [cited by applicant]
US 20120310315A1 · Savage et al. · 2012 [cited by applicant]
US 20130085538A1 · Volpe et al. · 2013 [cited by applicant]
US 20130231711A1 · Kaib · 2013 [cited by applicant]
US 20130245388A1 · Rafferty et al. · 2013 [cited by applicant]
US 20130274565A1 · Langer et al. · 2013 [cited by applicant]
US 20130317852A1 · Worrell et al. · 2013 [cited by applicant]
US 20130325078A1 · Whiting et al. · 2013 [cited by applicant]
US 20140025131A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140070957A1 · Longinotti-Buitoni et al. · 2014 [cited by applicant]
US 20140163663A1 · Poddar et al. · 2014 [cited by applicant]
US 20140324112A1 · Macho et al. · 2014 [cited by applicant]
US 20140378812A1 · Saroka et al. · 2014 [cited by applicant]
US 20150039053A1 · Kaib et al. · 2015 [cited by applicant]
US 20150265845A1 · Sullivan et al. · 2015 [cited by applicant]
US 20150328472A1 · Sullivan et al. · 2015 [cited by applicant]
US 20160004831A1 · Carlson et al. · 2016 [cited by applicant]
US 20160007877A1 · Felix et al. · 2016 [cited by applicant]
US 20160082277A1 · Foshee, Jr. et al. · 2016 [cited by applicant]
US 20160278659A1 · Kaib et al. · 2016 [cited by applicant]
US 20170056682A1 · Kumar et al. · 2017 [cited by applicant]
US 20180093102A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180117299A1 · Gustavson et al. · 2018 [cited by applicant]
US 20180184933A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180185662A1 · Foshee, Jr. et al. · 2018 [cited by applicant]
US 20180221648A1 · Gustavson et al. · 2018 [cited by applicant]
US 20180318593A1 · Sullivan · 2018 [cited by applicant]
US 20190030351A1 · Sullivan et al. · 2019 [cited by applicant]
US 20190030352A1 · Sullivan et al. · 2019 [cited by applicant]
WO 9839061A2 · 1998 [cited by applicant]
Duncker et al. “Real-world Experience of 355 Consecutive Patients with a Wearable Cardioverter/Debrillator—Single Centre Analysis” Europace 2017, No. 19 Supplemental 3, iii304. [cited by applicant]
Heartstart MRx and XL AED Algorithm—Application Note, Jul. 2001, Edition 2 Philips Healthcare, USA. [cited by applicant]
Klein, H. U., Goldenberg I., & Moss, A. J., Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update, European Heart Journal, May 31, 2… [cited by applicant]
LIFECOR LifeVest System Model WCD 3100 Operator's Manual, 2006, PN 20B0040 Rev FI, Zoll Lifecor Corporation, Pittsburgh, PA. [cited by applicant]
LifeVest Model 4000 Patient Manual, Zoll, 2009, PN 20B0047 Rev B. [cited by applicant]
Olgin JE, Pletcher MJ, Vittinghoff E, et al., “Wearable Cardioverter-Defibrillator after Myocardial Infarction,” N Engl J Med Sep. 27, 2018; 379(13):1205-1215. [cited by applicant]
Pagan-Carlo, et al., “Encircling Overlapping Multipulse Shock Waveforms for Transthoracic Defibrillation,” JACC Journals, Dec. 1998, vol. 32 Issue 7, pp. 2065-2071. [cited by applicant]
Schuhmann et al., “Experience with the wearable cardioverter defibrillator (WCD) in high risk cardiac patients from a German single center cohort”, Heart Rhythm 2016;13(5):S254. [cited by applicant]
WCD Performance for Clinical Review, Sullivan et al., “A Novel Wearable Cardioverter Defibrillator With Reduced False Alarm Rate,” AHA 2017. [cited by applicant]
Zoll, LifeVest, Proven protection from Sudden Cardiac Death, issued Mar. 27, 2018, 4 pages. Pittsburgh PA, USA. [cited by applicant]